KLRS
Kalaris TherapeuticsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
KLRS vs peer average
72/100
KLRS vs. peer average (B vs. C)
Grade spread
B 3 · C 2 · D 3 · F 2
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
CBUS is the first available peer comparator.
Same-sector micro-cap biotech peer, but only a loose size and event-risk comparator; pipeline maturity and financing needs are not close matches.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
KLRS
Kalaris Therapeutics
CBUS
Cibus
Grade
B
B
Momentum
74
100
Value
42
41
Sentiment
67
43
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs CBUS
KLRS / CBUS
Grade Position
Above peers
KLRS vs. peer average (B vs. C)
72/100
Momentum
74
CBUSValue
42
KLRSSentiment
67
KLRSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs KLRS
CBUS is the first peer returned for this comparison set.